Induction of in vitro differentiation and immunoglobulin synthesis of human leukemic B lymphocytes by unknown
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Chronic lymphocytic leukemia (CLL)t in man has been proven to be mainly a
disease due to clonal proliferation of B lymphocytes. Although immunofluorescent
studies indicate that the majority of the leukemic lymphocytes from patients with
CLL bear surface immunoglobulin (Ig), it has been shown that very little intracellular
Ig was demonstrable by this technique (2-4) . It appears that a differentiation block
is present in the majority of CLL cases. However, this block has been proven to be
incomplete in certain patients (5, 6) .
In a previous investigation involving a patient with CLL and a monoclonal IgM
band (5), an anti-idiotypic antiserum also identified a small number ofthe cells to be
plasma cells. Thus the IgM on the membrane of the lymphocytes, the intracellular
IgM in the plasma cells, and the monoclonal IgM protein in the serum were
idiotypically identical. It appeared that a small number of the leukemic lymphocytes
matured by a process of differentiation in vivo to plasma cells which synthesized the
serum monoclonal IgM.
The present studies indicate that leukemic B cells in these cases could be induced
to differentiate to plasma cells in vitro at an accelerated rate with the provision of
helper T cells. A T-cell helper function defect was demonstrated in these patients
which may have played a role in the limited differentiation in vivo.
Materials and Methods
Isolation ofLymphocytes.
￿
Mononuclear cells were isolated by Ficoll-Hypaque gradients (Phar-
macia Fine Chemicals, Piscataway, N. J.) from the peripheral blood of normal individuals and
patients with CLL. Tonsillar mononuclear cells were isolated as described previously (7) .
Spontaneous rosette formation between human lymphocytes and sheep erythrocytes (SRBC)
was performed with neuraminidase-treated SRBC (EN) . The E rosette-forming cells were
separated from the nonrosette"forming cells by Ficoll-Hypaque gradient centrifugation. The
rosette-forming cell fraction was purified further by a second density gradient centrifugation.
Repeated gradient centrifugation was performed until no significant cells were observed at the
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interphase. The E rosette-forming cells were recovered after lysis of SRBC by a Tris-buffered
ammonium chloride solution. Tonsillar B-cell fractions were obtained by the depletion of E
rosette-forming cells from the mononuclear cell preparations.
Patient Identification.
￿
Two patients wth CLL and monoclonal protein bands were studied.
Patient Ei has been described previously (5) . Patient Se is a 62-yr-old woman who had CLL for
3 yr. On her initial presentation, her leukocyte count was >50,000/mm3. An IgMic band of 4
mg/ml was present in the serum. In addition, lymphocytic infiltrate of liver and lungs was seen
in biopsy specimens. Marked splenomegaly was noted. After splenectomy and a short course of
chemotherapy, the leukocyte count decreased. At the time of this investigation, her leukocyte
count was 12,000/mm3 with 54% lymphocytes. 17% of the peripheral blood mononuclear cells
were monocytes identified by the presence of peroxidase granules, 42% were T cells, and 34%
stained with an anti-idiotypic antiserum against IgM Se. 0.2% of the mononuclear cells were
plasma cells stained brightly with the anti-idiotypic antiserum for intracellular Ig. Other CLL
patients had no detectable Ig bands.
Anti-Ig Antisera, Immunofluorescence, and Hemagglutination Antisera.
￿
Antisera were prepared in
New Zealand Red rabbits against the serum IgM components from these patients after
purification by Pevikon block electrophoresis. Rhodamine-conjugated F(ab~2 fragments specific
for 1,, "Y, a, K, X, IgM protein Se (IgM Se) and IgM protein Ei (IgM Ei) were prepared and
characterized by methods previously described (5) . Unconjugated idiotypic antisera specific for
IgM Ei and for IgM Se were also prepared. These antisera were absorbed with pooled normal
human serum, pooled IgG, and monoclonal IgM proteins isolated from other patients, and
were shown to be highly specific for the protein used in the immunization both by hemagglu-
tination assay and by immunofluorescence . Idiotypic antiserum to IgM Se did not react with
normal B cells or with cells from patient Ei by fluorescence; the same individual specificity was
true for idiotypic antiserum to IgM Ei. Immunofluorescence for the detection of membrane Ig,
intracellular Ig, hemagglutination, and hemagglutination-inhibit ion were carried out as de-
scribed (2, 5).
Cell Cultures and Plaque-Forming Cell (PFC) Assay.
￿
Cell cultures in a total volume of 2 ml
were set up in 16-mm diameter wells of Linbro culture plates (Linbro Chemical Co., Hamden,
Conn.) at 37 °C with 5% C02 in RPMI 1640 supplemented with 0.2 mM glutamine, 1%
trypticase soy broth, 10,um/ml penicillin, 100 Ag/ml streptomycin, and 10% SRBC-absorbed
human AB serum. For the experiments to determine leukemic cell differentiation, the cultures
were carried out for 6 days. The cells were then counted, washed, and processed for immuno-
fluorescence microscopy for the determination of the number of plasma cells generated. For the
cultures involving tonsillar B cells, 1 X 108 SRBCs were added to the cultures as antigen. At
day 5, cells were harvested and assayed for PFCs against SRBC by the Jerne-Nordin PFC assay
procedure as modified by Fauci and Pratt (8) . Concanavalin A (Con A)-induced suppressor
cells were generated according to Haynes and Fauci (9). Pokeweed mitogen (PWM; Grand
Island Biological Co., Grand Island, N. Y.) was used at a final dilution of 1:100.
Measurement ofDNA Synthesis in Cultured Cells.
￿
At the termination of cultures, triplicate 0.1-
ml aliquots from each culture were transferred to a flat-bottom Linbro plate (6-mm diameter
wells) and pulsed with [3H]thymidine (2 ul of 1.0 mCi/ml of spec act 1.9 Ci/mM;
Schwarz/Mann Div., Becton, Dickinson & Co., Orangeburg, N. Y.) . After an 8-h incubation at
37°C cells were processed by a semiautomatic harvester for liquid scintillation counting.
Autoradiographic Techniques. Cultured cells were labeled for 8 h with 5 ul of [3H]-
thymidine (0.5 mCi/ml of specificity 1 .9 Ci/mM; Schwarz/Mann) added to a 2.0-ml culture
with 2 X 108 cells in the presence of PWM. For continuous labeling, repeated doses (2 111) of
[3H]thymidine were added at day 0, 3, 5, and 7. Labeled cells were washed extensively and
smears were made by cytocentrifugation . The slides were fixed and stained with the rhodamine-
conjugated anti-idiotypic antiserum. Autoradiographs were developed according to standard
procedures. No counterstaining was done. The labeling procedures did not effect the viability
and the rate of differentiation of Se cells. All labeled cells contained >20 grains per cell.
Results
Maturation of Leukemic Lymphocytes and the Allogeneic Helper Cells.
￿
Leukemic B cells
isolated from patient Ei when cultured alone or with autologous T cells were not able1572
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TABLE I
Maturation ofEi Leukemic Lymphocytes under the Influence ofAllogeneic Helper
Factors*
* Cells were cultured in 2 ml of RPMI-1640 supplemented with 10% pooled human
serum for 6 days. Plasma cells were identified by immunolluorescence with an
idiotypic antiserum; IgM Ei secretion was estimated by hemagglutination inhibition
with the idiotypic antiserum.
$ 2 X 106 syngeneic T cells were added to these cultures.
to mature to plasma cells (Table I). In the first experiment, only 1 X 104 plasma cells
were seen after a 6-day culture of 2 X 106 leukemic B lymphocytes. In contrast, 5.5
X 105 plasma cells were detected in a similar culture to which 2 X 106 allogeneic T
cells from a normal individual were added. This represents a 55-fold increase in
plasma cell generation. In the second experiment, >100-fold increase was observed.
Although most cultures were set up for 6 days, significant numbers of plasma cells
(3.5 X 10~ were generated at day 4 in one experiment. Similar results were obtained
with either the rhodamine-conjugated anti-idiotypic antiserum or the anti-y antise-
rum. In one experiment involving double fluorochromes, the anti-,u antiserum stained
the same cells as the anti-idiotypic antiserum. The staining of plasma cells by the
rhodamine-conjugated idiotypic antiserum is shown in Fig. 1. A rare plasma cell was
seen in a control culture in which <0.5% of cells stained brightly with anti-idiotypic
antiserum (Fig. la) . In contrast, many plasma cells were seen in cultures to which
allogeneic T cells were added. A representative field of such a culture is shown in Fig.
lb.
IgM Ei secreted into the culture supernate was assayed directly by a passive
hemagglutination-inhibition assay involving the idiotypic determinant. Even though
the cultures were carried out in medium supplemented with normal AB serum, direct
assaying for specific IgM Ei secretion was feasible. Very little IgM Ei secretion (1
,ug/ml) was found in the supernate when the leukemic B cells were cultured alone. A
16-fold increase in IgM Ei secretion was detected in the first experiment in the culture
of Ei cells to which allogeneic T cells were added. In the second experiment, a 32-fold
increase was detected. Similar results were obtained in two additional experiments in
which allogeneic T cells were obtained from two different normal donors.
The second patient, Se, was studied in a similar fashion. Leukemic B lymphocytes
isolated from her peripheral blood also matured to plasma cells when they were
cultured with allogeneic T cells from a normal individual. In a typical experiment,
over 100-fold increase in specific IgM Se secretion was detected in the culture to which
allogeneic T cells were added.
Isolated T cells from Ei and Se responded to phytohemagglutinin (PHA) in a
[3H]thymidine uptake assay. Ei T cells gave a reduced response (30-50% of normal T
Ei B cells Allogeneic T cells
Plasma cells/cul-
cure
IgM Ei secreted
!+g
Exp. 1
2.0 X 106 None$ 1 X 104 0.1
2.0 X 106 2.0 X 106 5.5 X 105 1.6
Exp. 2
2.0 X 106 None$ 5 X 103 0.1
2.0 X 106 2.0 X 106 6.2 X 105 3.2S. M . FU, N . CHIORAZZI, H . G . KUNKEL, J . P . HALPER, AND S . R . HARRIS 1573
FIG . 1 .
￿
Staining of plasma cells with idiotypic antiserum in cultures containing similar numbers
of leukemic cells. (a) A rare plasma cell in the control culture containing only Ei leukemic B cells .
(b) Plasma cells in a culture of Ei leukemic B cells to which allogeneic normal T cells were added .
cells) to Con A and PWM, whereas Se T cells gave a normal response to PWM and
a reduced response to Con A. Both T cells gave a reduced response to allogeneic B
cells (30-40%) in a mixed lymphocyte culture reaction .
Aseries ofstimulatorysubstances such asCon A, PHA, streptokinase-streptodornase
(SKSD), tetanus toxoid, protein A, and dimethylsulfoxide were also added to Ei B
cells . No further differentiation was observed . Limited experiments were done with
supernates from mixed lymphocyte cultures . Only a 5- to 10-fold increase in plasma
cells were seen .1574
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TABLE II
Effect of PWMon the Differentiation ofSe Leukemic BLymphocytes*
* Culture conditions and assay systems were identical to those described in Table I.
PWM was added to a final dilution of 1 :100.
PWM-Induced Maturation of Leukemic B Cells.
￿
As reported previously (5), repeated
attempts to induce further maturation of leukemic B cells from the patient Ei with
PWM were unsuccessful. PWM induction of plasma cell generation by normal B cells
has been shown to be T-cell dependent (10) . To rule out that an insufficient number
of T cells in the unseparated mononuclear cell preparation was responsible for these
unsuccessful attempts, T cells from the patient Ei were isolated in a sufficient quantity.
As many as 1 X 107 autologous T cells from this patient failed to help 2 X 106
leukemic B cells to mature further in the presence of PWM.
In the case of Se, unseparated peripheral blood mononuclear cells were able to
mature to plasma cells stainable with an anti-idiotypic antiserum in the presence of
PWM. To study the T-cell dependence of this phenomenon further experiments were
carried out on isolated T and B cells from this patient. Se B cells did not respond to
PWM with autologous T cells in the absence of PWM. As little as 0.5 X 106
autologous T cells were sufficient to allow significant numbers of the leukemic B cells
to mature to plasma cells in the presence of PWM (experiment 1, Table II) . A
concomitant increase in specific IgM Se secretion was also detected in these cultures.
In the second experiment, similar results were observed.
Experiments were also carried out to determine if cell division was needed for Se
leukemic B cells to mature to plasma cellsunder the influence ofPWM and autologous
T cells. In an 8-h labeling experiment with [3H]thymidine at day 3, 5, and 7, only
10-15% of the plasma cells identifiable by immunofluorescence had grains by auto-
radiography. By day 3, >30% of the nonrosetting cells were plasma cells. In a
continuous labeling experiment, only 28% of the plasma cells were labeled by day 7.
Lack of Excessive Suppressor Cell Activity in Patients with CLL.
￿
Isolated T cells from
patient Ei were added to cell cultures in which Ei B cells and allogeneic T cells were
cocultured to assess suppressor cell activity of Ei T cells. As many as 1 X 107 T cells
from this patient failed to suppress the generation of plasma cells in this allogeneic
culture system.
Experiments were also carried out in the case of Se to rule out excessive suppressor
activity in a different assay system. The suppressor activity of a cell preparation was
determined by its ability to suppress the responses to PWM by the autologous
mononuclear cells. In such a system, 0.75 X 106 cells from normal individuals cultured
Se B cells Se T cells Plasma cells/cul-
ture
IgM Se secreted
1-L8
Exp. 1
1 .0 X 106 None 2 X 103 0.1
1 .0 X 106 0.5 X 106 4 X 106 6.4
1 .0 X 106 1.0 X 106 3.2 X 106 6.4
Exp. 2
1 .0 X 106 None 1 X 103 0.25
1 .0 X 106 1.25 X 106 3.8 X 106 4.0
1 .0 X 106 2.5 X 106 5.7 X 106 8.0S. M. FU, N. CHIORAZZI, H. G. KUNKEL, J. P. HALPER, AND S. R. HARRIS 1575
TABLE III
Lack of Suppressor Cell Activity in the Peripheral Blood ofPatient Se in a System ofPWM-Induced
Proliferation and Generation ofPlasma Cells*
Treatment ofcultured cells
* Cultures were set up under identical conditions described in Table I.
$ In a similar culture without the presence of PWM, 2 X 103 plasma cells per culture and 2,188 cpm
[3H]thymidine incorporation were observed. Plasma cells were identified with an anti-idiotypic antiserum
specific for IgM Se.
TABLE IV
Lack ofAllogeneic Helper Activity ofIsolated T Cellsfrom Patients with
CLL, using Tonsillar B Cells as a Test System*
* 2 X 106 tonsillar B cells were cultured either alone or with T cells under
identical conditions as described in Table I.
in the medium alone for 48 h would suppress significantly the generation of plasma
cells when added to a culture of freshly isolated autologous cells stimulated by PWM
(20-30% inhibition) . A more marked suppression was observed in the Con A-induced
suppressor system. As little as 0.375 X 106 cells cultured in the presence of 10 g,g/ml
of Con A inhibited both cell proliferation by 40% and plasma cell generation by 70%
in a similar system. In contrast to the normal control, relatively larger numbers of Se
mononuclear cells either cultured alone or in the presence of Con A were needed to
induce significant suppression of both proliferative and differentiative responses by
freshly isolated Se mononuclear cells to PWM stimulation (Table III). The prolifer-
ative response of Se cells to 10 gg/ml of Con A after 48 h was approximately 50% of
the normal control response as measured by [3H]thymidine uptake.
Defective T-Cell Helper Function in Patients with CLL.
￿
Because of the observation that
the provision of appropriate T-helper activities markedly increased the rate of
differentiation of leukemic B cells in vitro, the helper function of purified T cells from
patients with CLL was examined. The system employed for assaying the helper
activity of a given T-cell population was the generation of PFC by normal tonsillar
B cells against SRBC cocultured with the T cells (7) . In such a system, few plaques
were generated in a culture containing 2 X 106 B cells without the addition of
allogeneic T cells from normal individuals (Table IV) . In contrast, 1,200 plaques were
Cultured cells Medium alone 10 ttg Con A/ml of medium
Plasma cells/cul-
ture
[3H]Thymidine up-
take Plasma cells/cul-
ture
[3H]Thymidine up-
take
cpm cpm
- 5.7 X 105$ 68,145$
3.0 X 106 4.2 X 105 43,284 3.6 X 105 18,217
1.5 X 106 4.9 X 105 51,851 4.2 X 105 30,206
0.75 X 106 6.3 X 105 56,670 4.1 X 105 41,521
T-cell source (2 X 106) PFC against sheep erythrocytes
None 6
Normal 1,200
Ei 6
Se 3
Ya 31576
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seen when T cells from a normal person were added. The addition ofan equal number
of purified T cells from three patients with CLL (Ei, Se, and Ya) generated no
additional plaques . Ya is a patient without a monoclonal serum protein band. Further
experiments with additional cases are being published separately (11) .
Discussion
In the present studies, the leukemic B lymphocytes from two cases of CLL with
monoclonal IgM protein in their serum were induced to differentiate further to
plasma cells under the influence of the allogeneic helper effect (review in 12) generated
in the cultures of these leukemic cells and T cells from normal individuals. In one of
the cases, the leukemic B cells were able to mature further in the presence of PWM
and autologous T cells. The origin of these plasma cells were proven to be derived
from the leukemic cells by the use of idiotypic antisera specific for the membrane Ig
of the leukemic cells. In addition, a marked increase in specific IgM secretion was
detected in the supernates of the cultures. Evidence was also obtained by the
combination of immunofluorescence and autoradiography that the majority of the
leukemic B cells were able to mature to plasma cells without cell division. These in
vitro observations support further the previous conclusion that some plasma cells were
derived from leukemic cells in vivo by a process of differentiation (5) . The possibility
that these plasma cells might derive from a separate clone has been ruled out.
As many as 50% of the leukemic B cells were induced to mature to plasma cells in
some experiments. In comparison this rate of differentiation in vivo (0.1-2 .0%) was
markedly reduced. This reduced rate could not be due to an intrinsic defect of the
leukemic cells. In the present investigation, excessive spontaneous suppressor T-cell
activities were not found in the two cases studied. In the case of Se, Con A-induced
suppressor activities were also shown to be reduced. These findings are in agreement
with the previous report regarding suppressor activity in CLL cases (13) . Therefore,
it appears that excessive suppressor activities are not responsible for the reduced rate
of differentiation in vivo.
The isolated T cells from both patients were found to be defective in the generation
of allogeneic effect factors when they were cultured together with normal B cells. This
defect in helper T cells has been found in the majority of patients with CLL, even in
cases in which lymphocytosis was the sole manifestation ofthe disease (11) . In contrast,
this defect in T cells was not found in the patients with Waldenstrom's macroglobu-
linemia. In this regard, the cases of CLL with a monoclonal IgM band differ from
classic macroglobulinemia. The two cases studied also differ from each other in the
ability of their T cells to help autologous leukemic B cells to mature in the presence
of PWM. In the case of Se, T cells responded normally to PWM stimulation by cell
divisions and by the secretion of helper factors for the maturation of Se leukemic B
cells. In the case of Ei, the isolated T cells had a reduced response to the mitogen and
did not help Ei B cells. Thus, there is heterogeneity in the T-cell helper defects in
these patients. The isolated T cells were also found to be relatively deficient in the
subset of T cells bearing F,, receptors for IgM (11) . This subset of T cells has been
shown to be involved in both helper and suppressor functions in man (14). The lack
of T 1i cells might account for the T-cell defects observed in our cases.
Maino et al. (15) have demonstrated that leukemic lymphocytes synthesize mono-
clonal light chains and that this synthesis is increased in the presence of phytohemag-
glutinin (PHA). They did not observe the differentiation described in the presentS. M. FU, N. CHIORAZZI, H. G. KUNKEL, J. P. HALPER, AND S. R. HARRIS 1577
study; however, cases with monoclonal bands were not specifically studied. PHA had
no effect in the differentiation to plasma cells in our two cases. Also it was reported in
a case of prolymphocytic leukemia that a B-cell response to PWM occurred, although
it was not proven that the leukemic cells were involved or if a monoclonal band was
present in the serum (16) . Whether leukemic B cells in CLL cases without Ig
monoclonal proteins will differentiate further to plasma cells when appropriate helper
factors are identified and provided remains to be determined.
The two patients with CLL described above were severely ill with their disease;
patient Ei has died recently despite prolonged therapy. There was no apparent way
to separate these cases from most other patients with CLL except for the presence of
the monoclonal band. The latter was clearly an index of some differentiation in vivo.
In these cases, the leukemic B cells resemble normal B cells in the following manner.
They have IgM and IgD as their membrane Ig. The majority of the plasma cells
derived from these leukemic B cells in vivo have surface Ig but lack la-like antigens
on their surface (17). They are able to be transformed by Epstein-Barr virus, and
permanent lines have been obtained by such transformation (18). Finally, they are
responsive to T-cell regulation. Thus far no intrinsic defect in the leukemic B cells has
been evident. The demonstrated lack of helper T-cell activities in these cases may
contribute to the accumulation of leukemic lymphocytes at their early stages of
maturation. How significant this defect is and what role it might play in the
pathogenesis of the disease remains to be determined.
Summary
Successful induction of in vitro differentiation and immunoglobulin synthesis of
the leukemic lymphocytes was carried out in two cases of chronic lymphocytic
leukemia. Few plasma cells and little specific Ig secretion were detected in the cultures
of isolated leukemic B cells in either the presence or the absence of autologous T cells.
Up to 30% of the leukemic B cells matured to plasma cells, and a 32-fold increase in
specific Ig synthesis was observed when T cells from normal individuals were added
to the cultures of these leukemic B cells. In one of the two cases, autologous T cells
were able to induce >50% of the leukemic B cells to differentiate further to plasma
cells in the presence of pokeweed mitogen. This markedly accelerated in vitro
differentiation was only achieved with leukemic cells from cases in which there was
evidence of slight differentiation in vivo.
No evidence could be obtained for excessive suppressor T cells in these patients.
However, a T-cell defect in the generation of allogeneic effect helper factors was
identified. This defect may be responsible for the reduced rate of leukemic maturation
in vivo.
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